FDA Drug Application (202048) for LETROZOLE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number202048
Product Number001
FormTABLET;ORAL
Dosage2.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLETROZOLE
Active IngredientLETROZOLE

Active IngredientCount
List of drugs with Active Ingredient LETROZOLE2


Back to FDA Applications sponsored by LANNETT HOLDINGS INC